tropolone analog HDAC inhibitors (University of Connecticut)

N/A

Report date: 2025/03/20 09:36:09
NME

Base Information

Drug Nametropolone analog HDAC inhibitors (University of Connecticut)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 2 inhibitors
TargetsHistone deacetylase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Connecticut
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Connecticut
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A